Charles Nemeroff, MD, PhD - ADAA Chief Medical Officer and President-Elect

Charles B. Nemeroff, MD, PhD
Matthew P. Nemeroff Professor and Chair
Department of Psychiatry and Behavioral Sciences
Mulva Clinic for the Neurosciences
Director, Institute of Early Life Adversity Research

Dell Medical School, The University of Texas at Austin

Charles B. Nemeroff is currently the Professor and Chair, Department of Psychiatry and Director, Institute for Early Life Adversity Research. Previously, Dr. Nemeroff was the Leonard M. Miller Professor and Chairman of the Department of Psychiatry and Behavioral Sciences, and Clinical Director of the Center on Aging at the University of Miami Miller School of Medicine.  He is past president of the American College of Psychiatrists and the American College of Neuropsychopharmacology.  His research has focused on the neurobiology of mood and anxiety disorders with a focus on the long term consequences of child abuse and neglect and how these changes increase vulnerability for psychiatric disorders in adulthood.  He has published more than 1000 research reports and reviews, and 15 books.  He is a member of the Institute of Medicine of the National Academy of Sciences (USA).

Dr. Nemeroff has been an ADAA member since 1999, is the current President-Elect and was elected ADAA Chief Medical Officer in March, 2019.

Why I am an ADAA member

I have been a member of ADAA since its inception. It is a unique organization comprised of clinicians and scientists of various backgrounds.  This provides a rich environment for professional interactions.

What do I value about the ADAA mission and how does my work fit into the ADAA mission?  

ADAA has done a terrific job in educating the lay public on the nature of, and seriousness of mood and anxiety disorders. Being able to connect patients and providers with evidence-based treatments is of extraordinary importance.

What is the thing that I think is most exciting/interesting about what is currently happening in my lab or workplace? 

The long awaited goal of precision or personalized medicine in psychiatry—being able to predict the best treatment for individual patients is within our grasp.